High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitis
出版年份 2018 全文链接
标题
High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitis
作者
关键词
-
出版物
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 47, Issue 11, Pages 1472-1479
出版商
Wiley
发表日期
2018-04-18
DOI
10.1111/apt.14665
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Predicting corticosteroid-free endoscopic remission with vedolizumab in ulcerative colitis
- (2018) A. K. Waljee et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease
- (2018) A. Barré et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Pre-Morbid Obesity is Associated with Increased Risk of Developing Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis
- (2017) Siddharth Singh et al. GASTROENTEROLOGY
- Obesity is Associated with Inferior Response to Anti-TNF Therapy in Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis
- (2017) Siddharth Singh et al. GASTROENTEROLOGY
- Obesity is Associated with Worse Disease Activity in Patients with Inflammatory Bowel Diseases: An Internet Based Cohort Study
- (2017) Animesh Jain et al. GASTROENTEROLOGY
- American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases
- (2017) Niels Vande Casteele et al. GASTROENTEROLOGY
- Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience
- (2016) T. Billiet et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes
- (2016) Siddharth Singh et al. Nature Reviews Gastroenterology & Hepatology
- Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease
- (2015) M. Rosario et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Obesity in Inflammatory Bowel Disease: A Marker of Less Severe Disease
- (2015) Avegail Flores et al. DIGESTIVE DISEASES AND SCIENCES
- Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis
- (2015) Johannan F. Brandse et al. GASTROENTEROLOGY
- Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease
- (2015) Jennifer L. Seminerio et al. INFLAMMATORY BOWEL DISEASES
- Pharmacokinetics and Exposure–Efficacy Relationship of Adalimumab in Pediatric Patients with Moderate to Severe Crohnʼs Disease
- (2015) Shringi Sharma et al. INFLAMMATORY BOWEL DISEASES
- Measures of Obesity and Risk of Crohnʼs Disease and Ulcerative Colitis
- (2015) Hamed Khalili et al. INFLAMMATORY BOWEL DISEASES
- Effect of lifestyle weight loss intervention on disease severity in patients with psoriasis: a systematic review and meta-analysis
- (2015) S Upala et al. INTERNATIONAL JOURNAL OF OBESITY
- Impact of Bariatric Surgery on Patients With Rheumatoid Arthritis
- (2015) Jeffrey A. Sparks et al. ARTHRITIS CARE & RESEARCH
- Role of fat and adipokines in intestinal inflammation
- (2014) LeaI Kredel et al. CURRENT OPINION IN GASTROENTEROLOGY
- Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease
- (2014) Iris Dotan et al. INFLAMMATORY BOWEL DISEASES
- Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013
- (2014) Marie Ng et al. LANCET
- Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers
- (2013) Matteo Nicola Dario Di Minno et al. ANNALS OF THE RHEUMATIC DISEASES
- Increased Body Mass Index Is Associated with Earlier Time to Loss of Response to Infliximab in Patients with Inflammatory Bowel Disease
- (2013) Jason W. Harper et al. INFLAMMATORY BOWEL DISEASES
- Differences in Visceral Fat and Fat Bacterial Colonization between Ulcerative Colitis and Crohn’s Disease. An In Vivo and In Vitro Study
- (2013) Alessandra Zulian et al. PLoS One
- Predictors of dose escalation of adalimumab in a prospective cohort of Crohn’s disease patients
- (2011) E. Bultman et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now